Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,476 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification for sales revenues for April 2026
Regulatory Filings Classification · 90% confidence The document is a brief "Current report" under Art.100t of the Bulgarian Law on Public Offering of Securities, simply notifying monthly sales figures (April 2026 sales growth) without providing full financial statements or substantive interim report. It is a routine regulatory disclosure rather than a detailed earnings release or interim report. It falls under general regulatory filings.
2026-05-20 English
Notification for sale of treasury shares
Regulatory Filings
2026-05-19 Polish
Notification for sale of treasury shares
Transaction in Own Shares Classification · 90% confidence The document is a current report under EU MAR (Regulation (EU) No 596/2014) dated 18.05.2026 from Sopharma AD, notifying a sale of 46,000 treasury shares and detailing the post-transaction share count. This clearly falls under a transaction in the company’s own shares (share repurchase/issuance) and not a financial report or other category.
2026-05-18 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 95% confidence The document announces the sale of treasury shares by the company, specifying the number of shares sold, average price, total value, and remaining treasury shares. This clearly falls under a report of the company selling its own shares. Therefore, it matches “Transaction in Own Shares (Code: POS).”
2026-05-15 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 90% confidence The document is a formal announcement by the company of a sale of its own treasury shares, specifying number of shares sold, percentage of share capital, transaction value, and remaining treasury shares. This fits the definition of a Transaction in Own Shares (POS). It is not a full report, but a specific transaction announcement under EU market abuse rules.
2026-05-14 English
Notification for sale of treasury shares
Transaction in Own Shares Classification · 95% confidence The document is a short regulatory notice (724 characters) under Article 17 of EU Regulation 596/2014, disclosing that Sopharma AD sold 30,270 of its treasury shares and detailing the post-transaction share count. This is a corporate transaction in the company’s own shares (share repurchase/issuance), matching the definition of “Transaction in Own Shares (POS).”
2026-05-13 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.